Related Experiment Video
Updated: May 7, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Liver complications in inflammatory bowel diseases.
V Wieser1, R Gerner, A R Moschen
1Department of Internal Medicine I, Gastroenterology, Endocrinology and Metabolism, Innsbruck Medical University, Innsbruck, Austria.
Inflammatory bowel diseases (IBD) frequently cause liver and biliary tract complications, including primary sclerosing cholangitis (PSC), drug-induced liver injury, and non-alcoholic fatty liver disease (NAFLD). Awareness of these conditions is crucial for optimal patient care.
Area of Science:
- Gastroenterology and Hepatology
- Internal Medicine
Background:
- Liver and biliary tract diseases are common in patients with inflammatory bowel diseases (IBD).
- Key complications include primary sclerosing cholangitis (PSC), drug-induced hepatotoxicity, and non-alcoholic fatty liver disease (NAFLD).
Purpose of the Study:
- To review the spectrum and significance of liver complications in IBD patients.
- To highlight the clinical relevance of PSC, drug-induced liver injury, and NAFLD in the context of IBD.
Main Methods:
- Literature review and synthesis of current knowledge on IBD-associated liver diseases.
- Discussion of the etiology, clinical manifestations, and patient outcomes for each major liver complication.
Main Results:
- Primary sclerosing cholangitis (PSC), particularly associated with ulcerative colitis, leads to progressive biliary disease and increased cancer risk.
- Immunosuppressants like azathioprine can cause varied liver injuries, from enzyme elevation to severe cholestasis.
- Non-alcoholic fatty liver disease (NAFLD) may occur in IBD patients irrespective of traditional risk factors.
Conclusions:
- Liver complications affect 10-20% of IBD patients, necessitating physician familiarity.
- Early recognition and management of these liver conditions are vital for improving patient outcomes and care.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis

